NCT06864988Phase 3Active not recruiting

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Study sponsor: 4D Molecular Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-06Estimated

Enrollment · participants480Estimated

Source updated2026-06-01Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-03-25 · 1 field changed

Recruitment status

Recorded edit

− Previous value

Recruiting

+ Updated value

Active not recruiting

Check registry source

Posted 2026-01-07 · 1 field changed

Enrollment · participant count

Recorded edit

− Previous value

count: 400; type: ESTIMATED

+ Updated value

count: 480; type: ESTIMATED

Check registry source